CellRx is a manufacturer and supplier of growth factors that serve the technical research and bioprocessing markets.


Our first product to market is Short™ AE-IGF-1, a well-characterized, high potency, competitively priced alternative to insulin and other insulin-like analogues.

Learn more


CellRx also offers a range of specialist services to the bioprocessing industry including GMP contract manufacturing, bioprocess development and optimization.

Learn more

Management Team

Paul R Morrill, PhDFounder and Chief Executive Officer
Paul has over 30 years’ experience in the biotechnology and pharmaceutical sectors having held senior positions at Microgenics, Boeringher Mannheim, Acumen Biosciences, and, most recently, Horizon Discovery plc. In addition, over a 3-year period working in conjunction with Novo Nordisk, he worked on the downstream process of Factor VII. He has a strong and proven track record in business, commercial and product innovation/ development and, as a business entrepreneur, has helped to found numerous biotechnology and technology companies over the past 14 years, including a commercial founder of Horizon Discovery Group plc.

Over the past 9 years, as President of Products at Horizon Discovery Group, plc, Paul was instrumental in forming a bioprocessing group that focused on creating gene-edited CHO cell lines that could impact the growing need within the industry for improved bioproducer cell lines. In addition, he led the efforts of standardization within the Molecular Diagnostics (including NGS, FISH and IHC) industries by creating a range of highly characterized cell based reference standards that allow for platform/assay/operator comparison and standardization. Paul originated and built the products group at Horizon Discovery, which encompassed Diagnostics, Bioproduction, and Engineered cell lines.

Paul holds a PhD in Biotechnology from the University of Cambridge, is the author and contributor of several peer reviewed papers and patents in the fields of diagnostics, down-stream processing and imaging arrays.

Omrajah Ramcharan, PhDChief Scientific Officer
Omrajah has over 25 years’ experience in the biotechnology sector having held senior positions at African Explosives and Chemical Industry (AECI), SA Bio-products and the Biotechnology Regional Innovation Centre. He is a successful leader in science and technology with proven abilities in developing, implementing and commercializing innovative technologies, products and bio-processes in South Africa.

Omrajah is also the Founder and Scientific Advisor for BioTech Solutions which focuses on Bioprocess Development and Bio-manufacturing.

Omrajah holds a PhD in Biotechnology from Lund University in Sweden and is the author and contributor of several peer reviewed papers in the fields of applied microbiology, bioprocessing and recombinant proteins.

Omrajah has been appointed as a Mentor for Biotech Start-ups in South Africa. He also holds a Research Fellow position at the University of KwaZulu Natal and is a member of the South African Council for Natural Scientific Professions.

Now Shipping

CellRx Short AE-IGF-1 is available now for world-wide shipping.

Order Now

CellRx Short AE-IGF-1 is available for laboratory research and large-scale in-vitro biopharmaceutical manufacturing use only. Not for diagnostic or therapeutic use.

Short™AE-IGF-1 is a registered trademark of CellRx Limited.